孤立的Pauci免疫性肺毛细血管炎的致命结局:一个病例报告
Zeinab El Mawla1, Ghinwa Hammoud2, Racha Abed El Hamid2
1Department of Pulmonary & Critical Care, Faculty of Medical Sciences Lebanese University Hadat Lebanon.
Respirology case reports
|October 18, 2024
概括
隔离性乳腺免疫性肺毛细血管炎 (IPIPC) 是一种罕见的肺血管炎. 早期诊断和干预对于管理这种情况至关重要,这可能导致严重的呼吸衰竭和死亡.
科学领域:
- 肺部病理学 肺部病理学
- 类风湿病学 类风湿病学
- 病理学 病理学 病理学
背景情况:
- 隔离性乳腺免疫性肺毛细血管炎 (IPIPC) 是一种罕见的小血管血管炎,仅影响肺部.
- 它会引起肺毛细血管的炎症,可能导致气囊出血和严重的呼吸损害.
- 由于经常缺乏全身症状和ANCA阳性,诊断可能具有挑战性.
研究的目的:
- 在患有类风湿性关节炎的年轻女性中呈现IPIPC病例.
- 突出与IPIPC相关的诊断挑战和管理困难.
- 强调对IPIPC的早期识别和干预的关键需求.
主要方法:
- 一个23岁的女性患者的病例报告.
- 诊断工作包括成像 (例如,胸部X射线,CT扫描),带有活检的支气管镜检查和组织病理学检查.
- 治疗涉及高剂量的皮质类固醇和静脉注射免疫球蛋白.
主要成果:
- 这名患者出现了血栓塞和呼吸困难,最终被诊断为IPIPC.
- 尽管进行了积极的治疗,但她的病情进展到呼吸衰竭和死亡.
- 该案例说明了IPIPC的快速恶化和高死亡率的潜力.
结论:
- IPIPC带来了重大的诊断和治疗挑战,通常没有典型的血管炎标志物.
- 通过成像,支气管镜检查和组织病理学即时识别是必不可少的.
- 虽然皮质类固醇和免疫抑制剂是标准的,但结果仍然可能很差,这强调需要改进治疗策略和及时管理,以减轻严重的呼吸道并发症和死亡率.
相关概念视频
01:25Endocarditis II: Clinical features and Diagnostic Tests
2
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
2
01:28Pneumonia IV: Management
304
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
304